Dr Stephen Best
With approximately 2% of the adult population affected, ophthalmology must look at creative and sustainable programs to tackle this common disease. Although there are improvements in our diag-nostic abilities, local studies have demonstrated that up to 50% of suffers remain undiagnosed and even more disturbing are studies that suggest that our treatments may not be as effective as required. Ophthalmology must take an active role in leadership to promote a multi-disciplinary collaborative approach that results in better outcomes for patients with glaucoma using recognized protocols. The future will rely on a team approach.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY